Dynamic alteration of gene expression induced by anticancer-agent exposure in gastric cancer cell lines

被引:7
|
作者
Takahashi, Tsunehiro
Saikawa, Yoshiro [1 ]
Nakamura, Rieko
Kumagai, Koshi
Takeuchi, Hiroya
Kubota, Tetsuro [2 ]
Kitagawa, Yuko
机构
[1] Keio Univ, Dept Surg, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ Hosp, Ctr Comprehens & Adv Med, Shinjuku Ku, Tokyo 1608582, Japan
关键词
gastric cancer cell line; cisplatin; 5-fluorouracil; low density array; messenger RNA quantification; THYMIDYLATE SYNTHASE; CARCINOMA CELLS; MTT ASSAY; CHEMOTHERAPY; RESISTANCE; CISPLATIN; MECHANISMS; FLUOROPYRIMIDINE; PROGRESSION; ACTIVATION;
D O I
10.3892/or_00000244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognosis for advanced gastric cancer remains very poor due to the limited effectiveness of chemotherapy agents. The range in efficacy of these chemotherapy agents is likely the result of various factors including gene expression. In addition, the emergence of drug resistance during chemotherapy can result in the undesirable outcome of patients experiencing the side effects of chemotherapy without benefiting in terms of tumor response. Gene expression profiling provides a unique opportunity to gain insight into the development of different types of gastric cancer. We applied the TaqMan low density array to investigate the expression of 96 genes in four gastric cancer cell lines (TMK-1, MKN-45, MKN-74 and CDDP-resistant MKN-74). The cell lines displayed different patterns of gene expression alteration after exposure to the chemotherapeutic drugs cisplatin and 5-fluorouracil. We also established that cisplatin-resistant MKN-74 cells do not show the same gene expression patterns as the parental MKN-74 cell line at 0, 8 and 24 It after CDDP exposure. This study reveals the underlying complexity of biological and pathological events and could, perhaps, contribute to new experimental protocols or treatments that would achieve a consistent and desirable outcome of chemotherapy.
引用
收藏
页码:451 / 459
页数:9
相关论文
共 50 条
  • [41] Gene expression changes as markers of early lapatinib response in a panel of breast cancer cell lines
    O'Neill, Fiona
    Madden, Stephen F.
    Aherne, Sinead T.
    Clynes, Martin
    Crown, John
    Doolan, Padraig
    O'Connor, Robert
    MOLECULAR CANCER, 2012, 11
  • [42] Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines
    Wada, Yoshiyuki
    Yoshida, Kazuhiro
    Suzuki, Takahisa
    Mizuiri, Hirozumi
    Konishi, Kazuo
    Konishi, Kazuo
    Ukon, Kei
    Tanabe, Kazuaki
    Sakata, Yu
    Fukushima, Masakazu
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (04) : 783 - 791
  • [43] Multiple expression profiles of drug resistant gastric cancer cell lines revail drug resistance associated miRNAs
    Chen, Zhangqian
    Guo, Hao
    Dou, Jianhua
    Nie, Yongzhan
    Fan, Daiming
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 659 - 660
  • [44] Alteration of DNA methylation status induced by epidermal growth factor in gastric cancer cell line, MKN-74
    Saikawa, Y
    Kubota, T
    Otani, Y
    Kitajima, M
    Modlin, IM
    ANTICANCER RESEARCH, 2003, 23 (1A) : 143 - 148
  • [45] Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines
    Ifere, Godwin O.
    Barr, Erika
    Equan, Anita
    Gordon, Kereen
    Singh, Udai P.
    Chaudhary, Jaideep
    Igietseme, Joseph U.
    Ananaba, Godwin A.
    CANCER DETECTION AND PREVENTION, 2009, 32 (04): : 319 - 328
  • [46] A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT
    Bryant, J. L.
    Britson, J.
    Balko, J. M.
    Willian, M.
    Timmons, R.
    Frolov, A.
    Black, E. P.
    BRITISH JOURNAL OF CANCER, 2012, 106 (01) : 148 - 156
  • [47] SELECTION OF 3 OUT OF 24 ANTICANCER AGENTS IN POORLY-DIFFERENTIATED GASTRIC-CANCER CELL-LINES, EVALUATED BY THE AUC/DELTA-IC50 RATIO
    NOZUE, M
    NISHIDA, M
    TODOROKI, T
    FUKAO, K
    TANAKA, M
    ANTI-CANCER DRUGS, 1995, 6 (02) : 291 - 302
  • [48] Changes in levels of expression of p53 and the product of the bcl-2 in lines of gastric cancer cells during cisplatin-induced apoptosis
    Ikeguchi, M
    Tatebe, S
    Kaibara, N
    Ito, H
    EUROPEAN SURGICAL RESEARCH, 1997, 29 (05) : 396 - 402
  • [49] Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-12 in gastric and colonic cancer cell lines and in human colorectal cancer
    Guo, JM
    Chen, HL
    Wang, GM
    Zhang, YK
    ONCOLOGY, 2004, 67 (3-4) : 271 - 276
  • [50] Cisplatin Induced the Expression of SEI1 (TRIP-Br1) Oncogene in Human Oral Squamous Cancer Cell Lines
    Li, Junan
    Vangundy, Zachary
    Poi, Ming
    ANTICANCER RESEARCH, 2020, 40 (01) : 67 - 73